This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2010 May 25;55(21):2343-5.

doi: 10.1016/j.jacc.2010.01.046.

Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon?

Ulrich Schotten, Sander Verheule, Benoit-Gilles Kerfant, Maura Greiser

PMID: 20488305
DOI: 10.1016/j.jacc.2010.01.046

Free article

Comparative Study

Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon?

Ulrich Schotten et al. J Am Coll Cardiol. 2010.

Free article

. 2010 May 25;55(21):2343-5.

doi: 10.1016/j.jacc.2010.01.046.

Authors

Ulrich Schotten, Sander Verheule, Benoit-Gilles Kerfant, Maura Greiser

PMID: 20488305
DOI: 10.1016/j.jacc.2010.01.046

No abstract available

PubMed Disclaimer

Comment on

Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium.
Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schöndube FA, Hasenfuss G, Belardinelli L, Maier LS. Sossalla S, et al. J Am Coll Cardiol. 2010 May 25;55(21):2330-42. doi: 10.1016/j.jacc.2009.12.055. J Am Coll Cardiol. 2010. PMID: 20488304

Similar articles

Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium.
Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, Schmitto JD, Seipelt R, Schöndube FA, Hasenfuss G, Belardinelli L, Maier LS. Sossalla S, et al. J Am Coll Cardiol. 2010 May 25;55(21):2330-42. doi: 10.1016/j.jacc.2009.12.055. J Am Coll Cardiol. 2010. PMID: 20488304
Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Doshi D, Morrow JP. Doshi D, et al. Rev Cardiovasc Med. 2009;10 Suppl 1:S46-52. Rev Cardiovasc Med. 2009. PMID: 19898288 Review.
Is ranolazine an antiarrhythmic drug?
Eckhardt LL, Teelin TC, January CT. Eckhardt LL, et al. Am J Physiol Heart Circ Physiol. 2008 May;294(5):H1989-91. doi: 10.1152/ajpheart.00285.2008. Epub 2008 Mar 28. Am J Physiol Heart Circ Physiol. 2008. PMID: 18375723 No abstract available.
A focus on antiarrhythmic properties of ranolazine.
Vizzardi E, D'Aloia A, Quinzani F, Bonadei I, Rovetta R, Bontempi L, Curnis A, Dei Cas L. Vizzardi E, et al. J Cardiovasc Pharmacol Ther. 2012 Dec;17(4):353-6. doi: 10.1177/1074248412442000. Epub 2012 Apr 6. J Cardiovasc Pharmacol Ther. 2012. PMID: 22492919 Review.
Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Makielski JC, Valdivia CR. Makielski JC, et al. Br J Pharmacol. 2006 May;148(1):4-6. doi: 10.1038/sj.bjp.0706713. Br J Pharmacol. 2006. PMID: 16520741 Free PMC article.

See all similar articles

Cited by

Na_V1.8 as Proarrhythmic Target in a Ventricular Cardiac Stem Cell Model.
Hartmann N, Knierim M, Maurer W, Dybkova N, Zeman F, Hasenfuß G, Sossalla S, Streckfuss-Bömeke K. Hartmann N, et al. Int J Mol Sci. 2024 Jun 2;25(11):6144. doi: 10.3390/ijms25116144. Int J Mol Sci. 2024. PMID: 38892333 Free PMC article.
Calcium Signaling Silencing in Atrial Fibrillation: Implications for Atrial Sodium Homeostasis.
Kaplan AD, Joca HC, Boyman L, Greiser M. Kaplan AD, et al. Int J Mol Sci. 2021 Sep 29;22(19):10513. doi: 10.3390/ijms221910513. Int J Mol Sci. 2021. PMID: 34638854 Free PMC article. Review.
Effect of Sodium-Glucose Co-transporter Protein 2 Inhibitors on Arrhythmia in Heart Failure Patients With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.
Yin Z, Zheng H, Guo Z. Yin Z, et al. Front Cardiovasc Med. 2022 May 18;9:902923. doi: 10.3389/fcvm.2022.902923. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35665272 Free PMC article.
Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation.
Sovari AA, Dudley SC Jr. Sovari AA, et al. Front Physiol. 2012 Aug 6;3:311. doi: 10.3389/fphys.2012.00311. eCollection 2012. Front Physiol. 2012. PMID: 22934062 Free PMC article.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science